PLA2G7 and diabetes mellitus: Full models for other key populations, i.e. full trial population, type 2 diabetes population, type 2 diabetes with high Lp-PLA2 activity, and those with no diabetes with lower Lp-PLA2, are presented in ESM Table 13 along with survival plots (ESM Fig. 5).